home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Vaccines of the future: from rational design to clinical development  
  May 21, 2001

Biochemistry / Immunology

 
     
  Institut Pasteur, Paris, France
June 27-29, 2001


On Wednesday October 17, 2001 from 4:30 p.m.
OPENING LECTURE
A . Lanzavecchia (CH):Generation of effector and memory T cells

Thursday October 18, 2001

FROM FUNDAMENTAL RESEARCH TO RATIONAL VACCINE DESIGN: ANTIGEN IDENTIFICATION AND DELIVERY

• R. Rappuoli (I): Reverse vaccinology • M. R. Alderson (USA): Use of T-cell expression cloning to identify vaccine targets for intracellular pathogens • E. L. Reinherz (USA): Fundamentals of immune recognition: implications for manipulating the T cell repertoire • P. Ricciardi-Castagnoli (I): Targeting dendritic cells: a rational approach for vaccine development • B. Rocha (F): The cellular basis of T cell memory • C. Leclerc (F): Rational design of new vectors • D. M. Klinman (USA): CpG adjuvant activity • G. M. Glenn (USA): Transcutaneous immunization: an emerging route of immunization and potent strategy for immunostimulation • H. S. Mason (USA): Clinical trials with edible plant vaccines: present status and future challenges

Friday October 19 , 2001

FROM RATIONAL DESIGN TO CLINICAL DEVELOPMENT

• S. Cole (F): Comparative genomics as a tool for tuberculosis vaccine design • B. Gicquel (F): Rational attenuation of Mycobacterium tuberculosis. Application for vaccine design • C. L. Silva (BR): Therapeutic vaccination against tuberculosis • C.A. Siegrist (CH): Neonatal vaccinology: adressing the challenge • A.V.S. Hill (UK): Immunisation against malaria and other intra-cellular pathogens: new challenges and opportunities • C. J. M. Melief (NL): CD4+ and dendritic cells requirements for optimal CD8+ CTL induction against tumors • T. Boon (B): Therapeutic vaccination with tumor antigens recognized by cytolytic T lymphocytes • M. Klein (F): Rationale for the development of HIV therapeutic vaccines • J. D. Cohen (B): Malaria vaccine development: a status report

Round table: CHALLENGES AND OPPORTUNITIES FOR VACCINE DEVELOPMENT
Chairman: P. Moingeon (F)
•J. Almond (F) • F. Andre (B) • P. Kourilsky (F) • J.L. Romet-Lemonne (F) - CONCLUDING REMARKS: P. Kourilsky (F)
 
 
Organized by: Institut Pasteur
Invited Speakers: On Wednesday October 17, 2001 from 4:30 p.m.
OPENING LECTURE
A . Lanzavecchia (CH):Generation of effector and memory T cells

Thursday October 18, 2001

FROM FUNDAMENTAL RESEARCH TO RATIONAL VACCINE DESIGN: ANTIGEN IDENTIFICATION AND DELIVERY

• R. Rappuoli (I): Reverse vaccinology • M. R. Alderson (USA): Use of T-cell expression cloning to identify vaccine targets for intracellular pathogens • E. L. Reinherz (USA): Fundamentals of immune recognition: implications for manipulating the T cell repertoire • P. Ricciardi-Castagnoli (I): Targeting dendritic cells: a rational approach for vaccine development • B. Rocha (F): The cellular basis of T cell memory • C. Leclerc (F): Rational design of new vectors • D. M. Klinman (USA): CpG adjuvant activity • G. M. Glenn (USA): Transcutaneous immunization: an emerging route of immunization and potent strategy for immunostimulation • H. S. Mason (USA): Clinical trials with edible plant vaccines: present status and future challenges

Friday October 19 , 2001

FROM RATIONAL DESIGN TO CLINICAL DEVELOPMENT

• S. Cole (F): Comparative genomics as a tool for tuberculosis vaccine design • B. Gicquel (F): Rational attenuation of Mycobacterium tuberculosis. Application for vaccine design • C. L. Silva (BR): Therapeutic vaccination against tuberculosis • C.A. Siegrist (CH): Neonatal vaccinology: adressing the challenge • A.V.S. Hill (UK): Immunisation against malaria and other intra-cellular pathogens: new challenges and opportunities • C. J. M. Melief (NL): CD4+ and dendritic cells requirements for optimal CD8+ CTL induction against tumors • T. Boon (B): Therapeutic vaccination with tumor antigens recognized by cytolytic T lymphocytes • M. Klein (F): Rationale for the development of HIV therapeutic vaccines • J. D. Cohen (B): Malaria vaccine development: a status report

Round table: CHALLENGES AND OPPORTUNITIES FOR VACCINE DEVELOPMENT
Chairman: P. Moingeon (F)
•J. Almond (F) • F. Andre (B) • P. Kourilsky (F) • J.L. Romet-Lemonne (F) - CONCLUDING REMARKS: P. Kourilsky (F)
 
Deadline for Abstracts: August 20, 2001
 
Registration: Industrial : 6 000 FF VAT excluded
Academic : 3 000 FF VAT excluded
E-mail: euroconf@pasteur.fr
 
  Posted by:   Ludovic Drye  
Host: cache.pasteur.fr
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.